Agglutination enhancer

US9797886B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9797886-B2
Application numberUS-201214123899-A
CountryUS
Kind codeB2
Filing dateJun 4, 2012
Priority dateJun 7, 2011
Publication dateOct 24, 2017
Grant dateOct 24, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The purpose of the present invention is to provide an agglutination enhancer which shows superior agglutination enhancing effect to those of conventional immunoagglutination enhancers, and the present invention relates to an agglutination enhancer for an immunoagglutination measurement method which comprises a polymer having a monomer unit shown by the following general formula [1]: (Wherein R 1 represents a hydrogen atom or a methyl group; R 2 and R 3 independently represent a methyl group or an ethyl group, respectively; X represents —NH— or an oxygen atom; n represents an integer of 1 to 6; and m represents an integer of 1 to 3), and an immunoagglutination measurement method in which, in the coexistence of the above-described agglutination enhancer for immunoagglutination measurement method, an antibody against analyte or an antigen for the analyte is brought into contact with the analyte to cause an antigen-antibody reaction.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of measuring agglutination, which comprises bringing an antibody or an antigen against an analyte into contact with the analyte, to cause an antigen-antibody reaction, in the presence of a polymer that is either (a) a homopolymer consisting of a monomer unit of formula [1]: wherein R 1 is a hydrogen atom or a methyl group; R 2 and R 3 are a methyl group, X is —NH— or an oxygen atom; n is an integer of 2 to 4; and m is an integer of 1 or (b) a copolymer consisting of (i) a monomer unit of formula [1]: wherein R 1 is a hydrogen atom or a methyl group; R 2 and R 3 are a methyl group, X is —NH— or an oxygen atom; n is an integer of 2 to 4; and m is an integer of 1, and (ii) a monomer unit of formula [2]: wherein R 4 is a hydrogen atom or a methyl group, and k is an integer of 4 to 8, to generate agglutination and form particles from the antigen-antibody reaction, and measuring the degree of agglutination of the particles based on a change of scattered light or transmitted light. 2. The method according to claim 1 , wherein the analyte is C-reactive protein (CRP), serum ferritin (Fer), prostate specific antigen (PSA), or creatine kinase-MB (CK-MB). 3. The method according to claim 1 , wherein the content of the monomer unit of formula [1] in the copolymer is 50% by mole or more and less than 100% by mole. 4. The method according to claim 1 , wherein the polymer has a weight-average molecular weight of 50,000 to 3,000,000 g/mol. 5. A method of measuring agglutination, which comprises bringing an antibody or an antigen against an analyte into contact with the analyte, to cause an antigen-antibody reaction, in the presence of a polymer that is either (a) a homopolymer consisting of a monomer unit that is or (b) a copolymer consisting of (i) a monomer unit that is and (ii) a monomer unit of formula [2-1-1]: to generate agglutination and form particles from the antigen-antibody reaction, and measuring the degree of agglutination of the particles based on a change of scattered light or transmitted light.

Assignees

Inventors

Classifications

  • G01N33/542Primary

    with steric inhibition or signal modification, e.g. fluorescent quenching · CPC title

  • containing nitrogen in addition to the carbonamido nitrogen · CPC title

  • containing oxygen in addition to the carboxy oxygen {, e.g. 2-N-morpholinoethyl (meth)acrylate or 2-isocyanatoethyl (meth)acrylate} · CPC title

  • Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding · CPC title

  • Esters containing nitrogen {, e.g. N,N-dimethylaminoethyl (meth)acrylate} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9797886B2 cover?
The purpose of the present invention is to provide an agglutination enhancer which shows superior agglutination enhancing effect to those of conventional immunoagglutination enhancers, and the present invention relates to an agglutination enhancer for an immunoagglutination measurement method which comprises a polymer having a monomer unit shown by the following general formula [1]: …
Who is the assignee on this patent?
Yamamoto Naoyuki, Masuda Tsutomu, Wako Pure Chem Ind Ltd
What technology area does this patent fall under?
Primary CPC classification G01N33/542. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).